GHK-Cu research extends far beyond cosmetics. Explore the science of copper peptides in wound healing, lung remodeling, anti-fibrotic effects, gene expression modulation, and neuroprotective research — with verified citations.
What Does the Research Say About Peptides for Skin and Hair? The cosmetic peptide industry is massive — but behind the marketing, there is genuine published research on peptides that influence collagen synthesis, skin remodeling, melanogenesis, and hair follicle signaling. Some of these compounds have robust preclinical evidence. Others have moved into clinical trials. And…
A comprehensive scientific review of peptide degradation pathways including oxidation, deamidation, hydrolysis, aggregation, and racemization — with practical guidance on buffer pH, temperature, excipients, and storage strategies to preserve peptide integrity in research settings.
A comprehensive chemistry primer covering peptide bond formation, planarity, the four levels of protein structure, disulfide bridges, cyclization strategies, and how SPPS builds peptides one bond at a time.
KPV is a tripeptide that inhibits NF-κB and reduces TNF-α, IL-1β, and IL-6 — the same targets as expensive biologics. 2026 research is expanding from IBD into gut-brain axis and skin inflammation models.
From the discovery of the incretin effect to semaglutide and triple agonists like retatrutide, trace the science of GLP-1 receptor signaling — including cAMP/PKA pathways, central appetite regulation, and cardiovascular protection.
Peptides and proteins are both built from amino acids, but their size difference creates major distinctions in structure, synthesis, bioavailability, and research applications. Learn where the boundary falls and why it matters for your research.
What Does the Research Say About Peptides and Tissue Healing? Tissue healing — whether tendons, joints, ligaments, or soft tissue — is one of the most extensively studied applications of peptide research. While anti-inflammatory drugs and physical therapy remain the conventional approaches to tissue repair, a growing body of preclinical and clinical evidence points to…
A deep-dive into thymus-derived peptides and immunosenescence research — thymic involution with age, Thymosin Alpha-1’s FDA orphan drug status and T-cell effects, Thymulin’s zinc-dependent modulation, and the broader landscape of immune aging.
Thymosin Alpha-1 is backed by over 100 clinical trials and approved in 35+ countries. In 2026, research is expanding into COVID-19 recovery, checkpoint inhibitor combinations, and aging immunity. Here’s the full update.
